【レポートの概要（一部）】
1. Report Overview
1.1 The Molecular Diagnostics Market Overview
1.2 Molecular Diagnostics Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
1.10 About Visiongain
2. Introduction to Molecular Diagnostics
2.1 What are In Vitro Diagnostic (IVD) Tests?
2.2 Classifying In Vitro Diagnostics
2.2.1 FDA Classifications
2.2.2 IVD Classification in Australia
2.2.3 The EC (European Commission) Classification
2.3 IVD Submarkets
2.3.1 Clinical Chemistry
2.3.2 Immunochemistry
2.3.3 Point-of-care Testing (Including Self-monitoring Blood Glucose Tests)
2.3.4 Molecular Diagnostics
2.3.4.1 Infectious Disease Testing
2.3.4.2 Oncology Testing
2.3.4.3 Blood Screening
2.3.4.4 Genetic Testing
2.3.4.5 Tissue Typing (HLA Testing)
2.3.5 Clinical Microbiology
2.3.6 Haematology/ Haemostasis
2.4 Regulation of the IVD and MDx Market
2.4.1 FDA and CLIA Regulation of IVD and MDx Tests
2.4.1.1 Regulation of IVD/MDx Tests in the EU: The EC (European Commission) Classification
2.4.2 Top Ten Challenges in Regulation for In-Vitro Diagnostics
2.4.2.1 Challenges in Regulations of MDx tests
2.5 Device Excise Tax: A Threat to the Diagnostics Manufacturers
3. The Molecular Diagnostics Segment Within the In Vitro Diagnostics Market, 2014-2024
3.1 Molecular Diagnostics in the IVD Market, 2013
3.2 Sales Forecast for the Global IVD Market 2014-2024
3.3 Molecular Diagnostics Gaining Greater Share of the IVD Market
4. The Molecular Diagnostics Market by Sectors, 2014-2024
4.1 The Molecular Diagnostic Market by Sectors, 2013
4.2 The Molecular Diagnostic Market by Sectors 2014-2024
4.2.1 Market Shares of the Molecular Diagnostics Sectors 2014-2024
4.3 The Infectious Disease Testing Market 2014-2024
4.3.1 Breakdown of the MDx Infectious Disease Testing Market by Disease, 2013
4.3.1.1 HPV Testing
4.3.1.2 CT/NT
4.3.1.3 HIV
4.3.1.4 Hepatitis C (HCV)
4.3.1.5 MRSA/ C. diff
4.4 The Oncology Testing Market, 2014-2024
4.4.1 Targeted Therapies: A Major Driver of the Oncology Testing Market
4.4.2 Molecular Diagnostics: Currently Concentrated on a Few Cancer Indications
4.4.2.1 Breast Cancer
4.4.2.2 Prostate Cancer
4.4.2.2.1 Pipeline Biomarker
4.4.2.2.1.1 TMPRSS2-ERG (OriGene)
4.4.2.2.1.2 PTEN
4.4.2.3 Colorectal Cancer
4.5 The Blood Screening Market 2014-2024
4.5.1 Grifols’ Acquisition of Novartis’s Blood Screening Unit
4.5.2 Leading Blood Screening Test Products
4.5.2.1 Cobas s 201 System (Roche Molecular)
4.5.2.2 Procleix Assays (Grifols)
4.6 The Genetic Testing Market 2014-2024
4.6.1 Genetic Testing by Clinical Impact Area
4.6.2 Genetic Testing: Potentially Many More Disease Indications
4.6.3 Cystic fibrosis
4.6.4 Factor V Leiden and Factor II Thrombophilia
4.6.5 Inflammatory diseases
4.6.5.1 Alzheimer’s Disease (AD)
4.6.5.2 Rheumatoid Arthritis
4.6.5.2.1 Vectra®DA (Crescendo Bioscience)
4.6.5.2.2 Quest Diagnostics: Biomarker Study
4.6.5.3 Rare Diseases
4.7 The Tissue Typing (HLA) Market 2014-2024
4.7.1 Tissue Typing: Next Generation Sequencing
5. The Leading Molecular Diagnostics National Markets, 2014-2024
5.1 Regional Breakdown of the Global MDx Market, 2013
5.2 The Global MDx Market Forecast 2014-2024
5.3 The Regional Market Shares of the MDx Market, 2014-2024
5.4 The US MDx Market 2013: Representing More than Half of the Global Market
5.4.1 The US MDx Market Forecast 2014-2024
5.4.1.1 United States: Diagnostic Reimbursement
5.5 The European MDx Markets Forecast, 2014-2024
5.5.1 Changes in the Shares of the Leading European Markets, 2014-2024
5.5.2 The German MDx Market Forecast 2014-2024
5.5.3 The French MDx Market Forecast 2014-2024
5.5.4 The Italian MDx Market Forecast 2014-2024
5.5.5 The Spanish MDx Market Forecast 2014-2024
5.5.6 The UK MDx Market Forecast 2014-2024
5.5.7 The Other European MDx Markets Forecast 2014-2024
5.6 The Japanese MDx Market Forecast 2014-2024
5.7 The Chinese MDx Market Forecast 2014-2024
5.7.1 China: Increasing Cancer Burden
5.8 The Brazilian MDx Market Forecast 2014-2024
5.9 The Russian MDx Market Forecast 2014-2024
5.10 The Indian MDx Market Forecast 2014-2024
5.10.1 India: Expansion of Healthcare Provisions
5.11 The South Korean MDx Market Forecast 2014-2024
5.12 The Mexican MDx Market Forecast 2014-2024
5.13 The Rest of the World Market Forecast 2014-2024
6. The Leading Companies in the Molecular Diagnostics Market, 2014-2024
6.1 Roche Diagnostics
6.1.1 Roche: Global Presence
6.1.2 Roche Diagnostics, 2014-2024
6.1.3 Roche Diagnostics Business Performance within the IVD Market, 2013
6.1.3.1 Molecular Diagnostics Sales Performance, 2013
6.1.3.2 Molecular Diagnostic Sales by Region, 2013
6.1.4 Roche Diagnostics: MDx Product Launches and Indication Expansion, 2014
6.1.4.1 Roche Diagnostics: Product Launch Plans, 2014
6.1.4.2 Roche: Recent M&A Activity and Strategic Partnerships
6.2 Hologic Gen-Probe
6.2.1 Hologic Recent Sales Performance by Business Segment, 2013
6.2.2 Hologic Molecular Diagnostics: Product Portfolio
6.2.3 Product Pipeline: Infectious Disease Focus, but Prostate Cancer Diagnostics Shows Promise
6.2.4 Changes in Molecular Diagnostic Operations Structuring
6.3 Qiagen
6.3.1 Sales and Recent Performance Analysis, 2013
6.3.2 Qiagen Sales by Region, 2013
6.3.3 Qiagen Sales by Segment, 2013
6.3.4 Qiagen: Molecular Diagnostics
6.3.5 Molecular Diagnostics: Product Expansion
6.3.5.1 QIASymphony
6.3.5.2 QuantiFERON-TB Gold: Expansion into China
6.3.5.3 Personalised Healthcare: Collaborative Efforts
6.3.5.4 Bioinformatics: Software Company Acquisitions
6.4 Becton, Dickinson & Company
6.4.1 Sales and Financial Performance, 2013
6.4.2 Sales and Financial Performance by Region, 2013
6.4.3 Becton Dickinson Diagnostics Sales and Financial Performance, 2012-2013
6.4.4 BD Diagnostics: Product Portfolio
6.4.5 BD Diagnostics: Mergers and Acquisitions
6.5 BioMérieux
6.5.1 Sales and Recent Performance Analysis, 2010-2013
6.5.2 Sales by Region, 2013
6.5.3 Sales by Technology, 2013
6.5.4 Molecular Diagnostics: Product Portfolio
6.5.5 Companion Diagnostics: Collaboration with GSK
6.5.6 Mergers and Acquisitions
6.5.7 bioTheranostics: Subsidiary for Oncology Diagnostics
6.6 Cepheid
6.6.1 Sales and Recent Performance Analysis, 2010-2013
6.6.2 Sales by Industry Segment, 2012-2013
6.6.3 Sales by Region, 2012-2013
6.6.4 Cepheid: Product Line
6.6.5 Cepheid: Business strategy
6.7 Agilent (Dako)
6.7.1 Sales and Recent Performance Analysis, 2013
6.7.2 Sales Performance by Business Segment, 2013
6.7.3 Agilent: Strong Player in Next Generation Sequencing
7. Qualitative Analysis of the MDx Market, 2014-2024
7.1 MDx market: Drivers and Restraints
7.2 SWOT Analysis of the MDx Market, 2014-2024
7.3 Strength
7.3.1 Patient Demographics
7.3.2 Increased Awareness
7.3.3 High Growth in Oncology Molecular Diagnostics
7.3.4 Increasing Laboratory Test Menus
7.3.5 Personalised Medicine: Optimising Treatment Outcomes
7.4 Weaknesses
7.4.1 Lack of Clear Regulatory Guidelines for Molecular Diagnostics
7.4.2 Reimbursement Challenges for Molecular Diagnostic Companies
7.4.2.1 Consolidation of Healthcare Systems Increases Pricing Pressure
7.4.2.2 Reimbursement Uncertainty Discourages Capital Investment
7.4.3 MDx: An Expensive, but Undervalued Diagnostic Tool
7.5 Opportunities
7.5.1 Next-generation Sequencing
7.5.2 Emerging Markets
7.5.3 The Emergence of New Microorganisms
7.6 Threats
7.6.1 US Medical Device Excise Tax
7.6.2 Gene Patents: Controversial Ruling
7.7 Porter’s Five Forces Analysis of the MDx Market
7.7.1 Rivalry Among Competitors [High]
7.7.2 Threat of New Entrants [Medium]
7.7.3 Power of Suppliers [Medium]
7.7.4 Power of Buyers [High]
7.7.5 Threat of Substitutes [High]
8. Expert Opinions
8.1 Mike Nugent, Worldwide Market Segment Leader BD MAX, BD Diagnostics
8.1.1 Becton Dickinson’s Leadership in Infectious Disease Molecular Diagnostics
8.1.2 BD MAX System: Becton Diagnostics Leading Product
8.1.3 The Changing Landscape of the MDx Industry
8.1.4 Cost: A Deterrent of MDx Use
9. Conclusions
9.1 The Molecular Diagnostics Market: Growing Market Share
9.2 Molecular Diagnostics: Oncology Testing Market Growth
9.3 Commercial Drivers of the Molecular Diagnostics Market
9.4 Commercial Restraints of the Molecular Diagnostics Market
9.5 Emerging Markets
9.6 Concluding Remarks
【レポート販売概要】
■ タイトル：世界の分子診断市場：感染症検査、癌検査、血液検査、遺伝子検査■ 英文：The Molecular Diagnostics (MDx) Market Forecast 2014-2024 : Opportunities for Leading Companies
■ 発行日：2014年10月
■ 調査会社：visiongain
■ 商品コード：VGAIN4120202
■ 調査対象地域：グローバル
- 世界の静電集塵器市場：Global Electrostatic Precipitator Market 2014-2018TechNavio's analysts forecast the Global Electrostatic Precipitator market to grow at a CAGR of 9.42 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase in government policies to reduce the emissions associated with coal-fired power generation. The Global Electrostatic Precipitator market has also been witnessing the shift towards developing …
- 一酸化炭素（CO）警報装置の世界市場ABSTRACTAbout Carbon Monooxide Alarm CO alarms provide protection from inhaling CO gas by detecting the presence of CO gas and alerting with a sound produced by the alarm. Carbon monoxide (CO), also known as the silent killer, is an odorless and colorless toxic gas that is released when a fossil or fuel is burnt incompletely. It can cause various health hazards depending on the amount of gas inhal …
- 世界のサルモネラ検査市場The report presents a detailed analysis of the Salmonella diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Salmonella definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - P …
- 砂糖菓子の世界市場2016-2020About Sugar Confectionary Sugar confectionery products have a high amount of sugar or sweetener. They are generally consumed as snack food. The global sugar confectionery market is divided into six major segments based on product type: hard-boiled sweets, caramels and toffees, gums and jellies, medicated confectionery, mints, and others. Sugar confectionery products are made available to consumers …
- Respiratory Diseases in Italy 2014: Market Outlook and Emerging OpportunitiesAbout This ReportThis new 281-page report from Venture Planning Group presents detailed analysis of the Italian Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. …
- 皮下針（Hypodermic Needles）のグローバル市場動向（2014-2018）About Hypodermic Needles A hypodermic needle is a hollow needle commonly used with a syringe to inject substances into the body or or to extract fluids from it. A hypodermic needle is used for rapid delivery of liquids or to inject substances that cannot be ingested. Hypodermic needles are broadly classified into non-safety and safety needles based on the safety feature associated with the device. …
- 戦場管理システム（BMS）の世界市場2016-2020About Battlefield Management Systems A battlefield management system (BMS) provides the military unit with an integrated common operating picture (COP) that utilizes collaborative planning tools to enhance decision-making skills of the troops. This system provides the flexibility to manage and control events at combat level and also increases the probability for the mission success. The main purpo …
- Inherited Orphan Blood Disorders Therapeutics Market to 2019 – Breakthrough Drugs Remain Elusive Against Backdrop of High Unmet NeedInherited Orphan Blood Disorders Therapeutics Market to 2019 - Breakthrough Drugs Remain Elusive Against Backdrop of High Unmet Need Summary GBI Research, the leading business intelligence provider, has released its latest research, “Inherited Orphan Blood Disorders Therapeutics Market to 2019 - Breakthrough Drugs Remain Elusive Against Backdrop of High Unmet Need”. The report provides insights in …
- 脂肪族アルコールの世界市場2019-2023About this market The emergence of China and India as manufacturing hubs is expected to have a positive influence on the fatty alcohols market. With these countries becoming important industrial hubs, demand for industrial and institutional cleaners is expected to increase and promote the market under review as fatty alcohols are widely used in cleaning products. Technavio’s analysts have predicte …
- 世界の細胞培養装置及び消耗品市場（2014-2018）About Cell Culture Cell culture is the in vitro growth of plant or animal cells for several applications such as research, cell studies, and biopharmaceutical production. Cell culture is a crucial step in tissue engineering and vaccine production. Cell culture instruments and cell culture consumables are necessary for the in vitro production of cell lines. Some essential cell culture instruments a …
- 世界のプリンテッド&フレキシブルセンサー市場動向（2012-2016）TechNavio's analysts forecast the Global Printed and Flexible Sensor market to grow at a CAGR of 0.84 percent over the period 2012-2016. One of the key factors contributing to this market growth is the low cost of manufacturing printed and flexible sensors. The market has also been witnessing the miniaturization of sensor devices. However, lack of technology standards could pose a challenge to the …
- 転移性卵巣がん(Metastatic Ovarian Cancer)：治療薬開発パイプライン動向（2015年上半期版）Metastatic Ovarian Cancer - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Metastatic Ovarian Cancer - Pipeline Review, H1 2015’, provides an overview of the Metastatic Ovarian Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Metastatic Ovarian Cancer, complete with comparative analysis at various stages, therapeutics asse …
- インフルエンザ診断の世界市場分析：タイプ別（急性インフルエンザ診断試験[RIDT]、逆転写ポリメラーゼ連鎖反応[RT-PCR]、細胞培養、その他 – 免疫蛍光、血清学）、エンドユーザー別（病院、研究所、POCT）、セグメント予測The influenza diagnostics market is expected to reach USD 3.3 billion by 2024, according to a new report by Grand View Research, Inc. Influenza, or "the flu," is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on public health. Influenza A virus poses a greater …
- Myelofibrosis：グローバル臨床試験レビューH2, 2013Myelofibrosis Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Myelofibrosis Global Clinical Trials Review, H2, 2013" provides data on the Myelofibrosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Myelofibrosis. It includes an overview of the trial numbers and their recruitment status as per the …
- 世界の誘導電気炉市場2015The Global Induction Furnace Industry Report 2015 is a professional and in-depth study on the current state of the Induction Furnace industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Induction Furnace market analysis is provided for the international markets including development trends, competitive …
